Aimee Aoi Sato

Aimee Aoi Sato, MD serves as Associate Professor of Neurology and Director of the Neurofibromatosis Program at Seattle Children's Hospital, where she has been on staff since September 2018. Board-certified in Child Neurology, she specializes in neurofibromatosis and brain tumor care within the Neurosciences Center.

Her educational background includes:

• Medical training at University of California San Francisco
• Residency at Children's National Medical Center, Washington, DC
• Fellowship at Children's National Medical Center, Washington, DC

Dr. Sato's research centers on Neurofibromatosis Type 1, Schwannomatosis (including NF2-related variants), and low-grade gliomas. Through the Ben Towne Center for Childhood Cancer and Blood Disorders, she leads the SC-4013 clinical trial developing evidence-based treatment criteria for NF1-associated optic pathway glioma, emphasizing translational applications for pediatric patients.

No scientific awards were documented in the source materials.

As Neurofibromatosis Program Director, she oversees multidisciplinary clinical care and research initiatives. Her SC-4013 trial represents active grant-supported work focused on optimizing treatment protocols for children with neurofibromatosis-related tumors.

She directs the Neurofibromatosis Program within Seattle Children's Neurosciences Center and collaborates with the Ben Towne Center team, integrating neurology, oncology, and supportive specialties to provide comprehensive care for children with neurofibromatosis spectrum disorders.